Cargene is a preclinical-stage biopharmaceutical company developing oligonucleotide therapeutics across a broad range of diseases.
Cargene has raised $19.2M in total funding. The most recent round was Seed. The last funding was announced in December 2021.
Cargene's investors include Legend Star, BioTrack Capital, Hyfinity Investments.
Cargene is headquartered in Cambridge, United States.
Cargene is a preclinical-stage biopharmaceutical company developing oligonucleotide therapeutics across a broad range of diseases.
Cargene is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cargene — Funding & Investors." VCBacked, December 14, 2021, https://www.vcbacked.co/company/cargene. Accessed August 15, 2026.
VCBacked. (2021). Cargene — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/cargene
{{cite web |title=Cargene — Funding & Investors |url=https://www.vcbacked.co/company/cargene |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated